The abundantly expressed calcium/calmodulin-dependent protein kinase II (CAMK2), alpha (CAMK2A), and beta (CAMK2B) isoforms are essential for learning and memory formation.
INTRODUCTION
Intellectual disability (ID), characterized by an IQ score of <70 and moderate to severe limitations in adaptive functioning, often has a genetic cause. Next generation sequencing (NGS) offers a powerful diagnostic modality for undiagnosed ID patients. Currently, despite the recent identification of more than 700 genes associated with ID, in approximately half of ID cases, the genetic pathogenicity cannot be established with certainty, since the mutation has not been identified before (Vissers, Gilissen, & Veltman, 2016) .
Calcium/calmodulin-dependent protein kinase type II (CAMK2) is a Ser/Thr protein kinase family consisting of four isozymes (CAMK2A, CAMK2B, CAMK2G, and CAMK2D). CAMK2A and CAMK2B have a highly abundant and neuron-selective expression. Targeted deletion of CAMK2A or CAMK2B in mice has revealed their indispensable requirement for normal cognition (Borgesius et al., 2011; Elgersma et al., 2002; Giese, Fedorov, Filipkowski, & Silva, 1998; Hell, 2014; Lisman, Schulman, & Cline, 2002; Lisman, Yasuda, & Raghavachari, 2012; Silva, Paylor, Wehner, & Tonegawa, 1992a; Silva, Stevens, Tonegawa, & Wang, 1992b; van Woerden et al., 2009) . Moreover, human CAMK2A and CAMK2B mutations have recently been established as a cause of ID (Küry et al., 2017) . In contrast to CAMK2A and CAMK2B, much less is known about the other CAMK2 isoforms, CAMK2G and CAMK2D. However, recently a de novo mutation in the CAMK2G gene (c.875G > C p.Arg292Pro, henceforth denoted as CAMK2G Arg292Pro ) was identified in a patient with severe ID (de Ligt et al., 2012) . In addition, here, we describe a second, unrelated individual with ID carrying the c.875G > C p.Arg292Pro mutation, strongly suggesting a causative role for CAMK2G in ID.
Even though the expression of CAMK2G in the adult brain is relatively low compared to CAMK2A and CAMK2B (Tobimatsu & Fujisawa, 1989) , CAMK2G is highly abundant in the developing nervous system in rats (Bayer, Löhler, Schulman, & Harbers, 1999) and in humans, where it is the dominant isoform in the first trimester in the hippocampus ( Figure 1A ). Other than a few studies, reporting associations of common variation in CAMK2G with reduced memory performance (de Quervain & Papassotiropoulos, 2006) , depression (Li et al., 2013) and chronic inflammatory pain (Pan et al., 2014) , and a recent study proposing that CAMK2G functions as a calcium/calmodulin (Ca 2+ /CaM) shuttle (Ma et al., 2014) , the mechanistic function of CAMK2G during neurodevelopment has remained largely unknown.
Here, we describe the clinical features of both individuals carrying the CAMK2G p.Arg292Pro mutation, the contribution of CAMK2G to neuronal migration in vivo and neuronal maturation in vitro and how the CAMK2G Arg292Pro mutation affects CAMK2G function. We found that reduced expression of CAMK2G leads to inappropriate precocious neuronal maturation. Moreover, we demonstrate that the p.Arg292Pro mutation is a pathogenic gain-of-function mutation, which renders the CAMK2G protein constitutively active, and causes a severe impairment of neuronal migration and maturation. Although the mutation also interferes with nuclear import, we found that the pathogenic effect we describe is not related to Ca 2+ /CaM shuttling.
Taken together, our findings establish CAMK2G as a critical regulator of neurodevelopment and propose a novel mechanism by which the ID mutation, CAMK2G Arg292Pro exerts its pathogenic effect.
MATERIAL AND METHODS

Identification of the CAMK2G p.Arg292Pro patients
Patient 1 was part of a whole-exome sequencing study performed on patients with severe intellectual disability in Nijmegen, the Netherlands (de Ligt et al., 2012) . Written consent for use of the patients' photos were obtained from the parents. Patient 2 was identified by clinical whole-exome sequencing done as part of a diagnostic evaluation through the Greenwood Genetic Center in South Carolina.
Constructs
The cDNA sequence from human CAMK2G WT (NM_172171.2, variant without NLS) was obtained from a human brain cDNA library by PCR (Phusion high fidelity, Thermo Fisher) using the following primers:
Fw 5 ′ ACATCTGGCGCGCCACCATGGCCACCACCGCCACCTG 3 ′ and Rev 5 ′ AAGTCCTTAATTAATTATCACTGCAGCGGTGCGGCAG 3 ′ and cloned into our dual promoter expression vector (Suppl. Fig.   S1 ). The cDNA sequence from rat CAMK2A WT and CAMK2B WT were kindly provided by Tobias Meyer and was cloned into our expression vector. The NLS version of CAMK2G WT was generated using 
Mice
For the neuronal cultures, FvB/NHsD females were crossed with FvB/NHsD males (both ordered at 8-10 weeks old from Envigo). For the in utero electroporation, female FvB/NHsD (Envigo) were crossed with male C57Bl6/J (ordered at 8-10 weeks old from Charles River). 
HEK-293T cell transfections
To test the expression vector with the CAMK2 constructs, to measure the phosphorylation levels of CAMK2, and for immunoprecipitation 
Immunoprecipitation
Two to three days after HEK transfection in 10 cm dishes, cells were harvested in PBS and cell pellets were taken up in 500 ul of IP lysis buffer (20 mM Tris pH 8.0, 150 mM NaCl, 1% NP40) supplemented with protease inhibitor cocktail (#P8340, Sigma), phosphatase inhibitor cocktail 2 (#P5726, Sigma), and phosphatase inhibitor cocktail 3 (#P0044, Sigma). Protein concentration in the samples was determined using the BCA protein assay kit (Pierce) and 600 ug of total protein adjusted to a volume of 800 ul was used for immunoprecipitation. 
Primary hippocampal cultures
Primary hippocampal and cortical neuronal cultures were prepared from FvB/NHsD wild-type mice according to the procedure described in Goslin and Banker (1991) . Briefly, hippocampi were isolated from brains of E16.5 embryos and collected altogether in 10 ml of neurobasal medium (NB, Gibco) on ice. After two washings with NB, the samples were incubated in pre-warmed trypsin/EDTA solution (Invitrogen) at 37 • C for 20 min. After 2× washing in pre-warmed NB, the cells were resuspended in 1.5 ml NB medium supplemented with 2% B27, 1% penicillin/streptomycin, and 1% glutamax (Invitrogen), and dissociated using a 5 ml pipette. Following dissociation, neurons were plated in a small drop on poly-d-lysine (25 mg/ml, Sigma) coated 15 mm glass coverslips at a density of 1×10 6 cells per coverslip in 12 well plates containing 1 ml of supplemented NB for each coverslip. The plates were stored at 37 • /5% CO 2 until the day of the transfection.
Neuronal transfection and immunocytochemistry
Neurons were transfected after 7 days in vitro (DIV) with the following 
In utero electroporation
The procedure was performed in pregnant FvB/NHsD mice at E14. The electrodes were placed in such a way that the positive pole was targeting the developing somatosensory cortex. The following plasmids were injected: control vector, CAMK2G WT , CAMK2G Arg292Pro ,
CAMK2A Lys291Pro , CAMK2B WT , and CAMK2B Lys292Pro or for knockdown experiments: a pool of the CAMK2G shRNAs with an RFP plasmid (Addgene) or the control shRNA with an RFP plasmid. After birth, pups (M/F) were sacrificed at P18-P22 for histochemical processing.
Immunohistochemistry
Mice were deeply anesthetized with an overdose of Nembutal and transcardially perfused with 4% paraformaldehyde. Brains were extracted and post-fixed in 4% PFA. Brains were then embedded in gelatin and cryoprotected in 30% sucrose in 0.1 M phosphate buffer, frozen on dry ice, and sectioned using a freezing microtome (40-50 m thick). Free-floating coronal sections were washed in 0.1 M PB and a few selected sections were counterstained with 4 ′ ,6-diamidino-2-phenylindole solution (DAPI, 1:10,000, Invitrogen) before being mounted with Mowiol on glass. Overview images of the coronal sections were acquired by tile scan imaging using a LSM700 confocal microscope (Zeiss) with a 10× objective. Zoom in images of the targeted area were taken using a 20× objective.
For the migration analysis, confocal images (10× objective, 0.5 zoom, 1024 × 1024 pixels) were taken from 2 to 3 non-consecutive sections from at least three successfully targeted animals per plasmid. Images were rotated to correctly position the cortical layers, and the number of cells in different layers were counted using ImageJ (Analyze particles option), and the results were exported to a spreadsheet for further analysis. Cortical areas from the pia to the ventricle were divided in 10 equal-sized bins and the percentage of tdTOMATOpositive cells per bin was calculated.
Statistical analysis
All data was assumed to be normally distributed. Statistical difference between the conditions for the in vitro overexpression experiments was determined using one-way analysis of variance (ANOVA) followed by Bonferroni's post-hoc test for multiple comparisons and for the knockdown experiments using the two-tailed unpaired t-test
(dual comparison). For the western blot analysis, one-tailed and twotailed unpaired t-test was used (dual comparison). For the in vivo exper-
iments on neuronal migration, the analysis was performed on the number of targeted cells, measured as sum of the first four bins, considered to correspond to the layers 2/3 of the somatosensory cortex.
Statistical analysis was performed using one-way ANOVA, followed by Bonferroni's multiple comparison tests. Based on previous experiments performed in our lab, we considered that for the neuronal experiments in vitro at least two replicates, with 10 neurons each were necessary. For the western blot analysis, we considered at least three replicates, and for the IUE experiments, previous experiments in our laboratory showed that at least three targeted pups were necessary to draw any conclusion about the migration. P-values are indicated in the figures with "*": * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.0001.
RESULTS
CAMK2G p.Arg292Pro mutation causes severe intellectual disability
Patient 1 carrying the CAMK2G p.Arg292Pro mutation has already briefly been described in a whole-exome sequencing study describing several individuals with severe ID (de Ligt et al., 2012 (Küry et al., 2017) .
Knockdown of CAMK2G causes increased neuronal arborization
Identifying two unrelated patients with a severe neurodevelopmental disorder carrying the same mutation in CAMK2G, strongly suggests that CAMK2G plays a role in neurodevelopment and neuronal functioning. However, whereas the indispensable roles of CAMK2A and CAMK2B for neuronal plasticity and cognitive function are well established, the neuronal function of CAMK2G remains poorly characterized. Considering the highly abundant expression of CAMK2G in the first trimester during which the nervous system starts to develop and the stable expression during the rest of the prenatal period (Figure 1A) , we set out to investigate the role of CAMK2G during neuronal maturation in vitro, using shRNAs to effect knockdown of the CAMK2G protein. We transfected mouse primary hippocampal neurons with shRNAs directed against Camk2g or a control plasmid, together with a red florescent protein (RFP) reporter plasmid to visualize transfected neurons. Despite the CAMK2G antibody cross-reactivity with CAMK2A and CAMK2B (Suppl. Fig. S3 ), we nevertheless observed a 35% reduction of immunofluorescent signal 5 days after transfection, without any change in CAMK2A or CAMK2B levels (Suppl. Figure 1C ). Additional quantification of the neurite length and arborization revealed that neurons with reduced levels of CAMK2G exhibited a 38% increase in total neurite length and 55% increase of arborization compared to the control condition ( Figure 1B and D, see figure legend for statistics). Mice express three CAMK2G isoforms, one of which contains a nuclear localization signal (NLS) (Suppl. Fig. S4A ). This isoform is present in both cytosol and nucleus and was recently proposed to shuttle Ca 2+ /CaM into the nucleus (Ma et al., 2014) . In order to assess to what extent the observed effect on neurite length and arborization was specific for the down-regulation of CAMK2G and whether there is differential contribution of the CAMK2G isoforms, we co-transfected either the human CAMK2G isoform lacking the NLS (CAMK2G), the CAMK2G isoform containing the NLS (CAMK2G-NLS), CAMK2A or CAMK2B together with the shRNA against mouse Camk2g. Whereas co-transfection of CAMK2A or CAMK2B with Camk2g shRNA had no effect on total neurite length (Suppl. Fig. S4B and C) , co-transfection of CAMK2G or CAMK2G-NLS with Camk2g shRNA both resulted in a complete rescue of the neuronal morphology phenotype caused by the down-regulation of CAMK2G ( Figure 1B-D and Suppl. Fig. S4B and C) . These results indicate that CAMK2G is indispensable for regulating neuronal morphology, but that this function does not require its nuclear import.
3.1.2
The CAMK2G Arg292Pro mutation is pathogenic both in vitro and in vivo
To study the effect of the ID-associated CAMK2G missense variant on neuronal function, we cloned the human CAMK2G gene with and without the c.875G > C mutation in a dual promoter expression vector (see Section "Material and Methods"). Transfection of HEK-293T cells with CAMK2G Arg292Pro achieved a 10-fold lower CAMK2G protein signal compared to that achieved by transfection with CAMK2G WT , despite equal tdTomato levels, indicating that the p.Arg292Pro mutation affects protein stability (Figure 2A and B) . Next, we investigated the effect of expression of CAMK2G WT and CAMK2G Arg292Pro in primary hippocampal neurons. Despite the reduced stability of CAMK2G Arg292Pro , levels of CAMK2G were increased in neurons transfected (tdTomato-positive) with CAMK2G Arg292Pro ( Figure 2C ).
Whereas expression of CAMK2G WT yielded no discernible morphological changes with respect to total neurite length or arborization, expression of CAMK2G Arg292Pro strongly reduced total neurite length as well as arborization, which was notably in the opposite direction as observed following Camk2g knockdown ( Figure 2D ). These results suggest that the p.Arg292Pro mutation functions as a pathogenic gain-offunction.
To evaluate the effect of CAMK2G Arg292Pro expression in vivo, we used in utero electroporation at E14.5. This assay measures the ability of targeted neural cells in the subventricular zone to successfully migrate to layer 2/3 of somatosensory cortex. This assay is very sensitive for changes that perturb normal neural cell function (Saito & Nakatsuji, 2001; Tabata & Nakajima, 2001; Taniguchi et al., 2012) .
Strikingly, cells expressing CAMK2G Arg292Pro exhibited a complete block of migration from the subventricular zone, despite more than 80% of the cells expressing CAMK2G WT having migrated normally to layer 2/3 of the somatosensory cortex ( Figure 2E and F). These results further confirm the severe dominant effect of the p.Arg292Pro mutation on CAMK2G function.
Taken together these data suggest that although CAMK2G Arg292Pro has reduced protein stability, this mutation does not lead to a loss of function of CAMK2G, but instead appears to result in a paradoxical Figure 3A and B), suggesting that the p.Arg292Pro mutation enhances phosphotransferase activity and acts as a gain-of-function mutation.
To further test whether the p.Arg292Pro mutation affects neuronal function by acting as a gain of function mutation, we first analyzed the effect of two mechanistically well-established loss-of-function CAMK2 mutations on neuronal migration and morphology. The CAMK2G Ala303Arg mutation prevents binding of Ca 2+ /CaM, and therefore Ca 2+ /CaM-dependent activation (Fink et al., 2003; Payne et al., 1988; Shen & Meyer, 1999) . In contrast, the CAMK2G Lys43Arg mutation impairs phosphotransferase activity (Fink et al., 2003; Shen & Meyer, 1999) . Notably, neither CAMK2G Ala303Arg nor CAMK2G Lys43Arg altered neurite length when expressed in cultured primary hippocampal neurons. Moreover, although a small but statistically significant increase of arborization was observed in CAMK2G Ala303Arg expressing neurons, no effect of arborization was found in neurons expressing CAMK2G Lys43Arg ( Figure 3C and D) .
Finally, in vivo neural cell migration was also unaffected by expression of CAMK2G Ala303Arg or CAMK2G Lys43Arg ( Figure 3E and F) . Taken 
CAMK2G-NLS Arg292Pro has impaired nuclear translocation while permitting calmodulin binding
Recently, it was shown that CAMK2G functions as a shuttle for Ca 2+ /CaM into the nucleus (Ma et al., 2014) . Hence, we investigated if the p.Arg292Pro mutation impacts this shuttling function. Using the nuclear localization signal-containing isoform of CAMK2G, we first confirmed the functional impact of CAMK2G-NLS Arg292Pro on (Heist, Srinivasan, & Schulman, 1998; Ma et al., 2014; Shioda, Sawai, Ishizuka, Shirao, & Fukunaga, 2015) . Given that the p.Arg292Pro mutation enhances the Serine/Threonine kinase activity of CAMK2G, we sought to investigate whether increased phosphorylation of the Ser334 residue is a critical mediator of the abnormal localization of CAMK2G-NLS Arg292Pro . Therefore, we generated the CAMK2G-NLS Ser334Ala mutant and the CAMK2G-NLS Arg292Pro/Ser334Ala double mutant constructs to assess their respective subcellular localization. Whereas CAMK2G-NLS Ser334Ala was localized in both the nucleus and the cytoplasm, CAMK2G-NLS Arg292Pro/Ser334Ala remained exclusively cytoplasmic, indicating that the mislocalization resulting from the p.Arg292Pro mutation is not the result of excessive Ser334 phosphorylation ( Figure 5C and D) .
Taken together, these data show that even though the p.Arg292Pro mutation does not reduce CaM affinity, it strongly impairs the nuclear localization of CAMK2G.
Pathogenicity of CAMK2G
Arg292Pro is not related to nuclear shuttling of Ca 2+ /CaM
Our findings indicate that the p.Arg292Pro mutation has two major effects on CAMK2G: it renders the protein constitutively active and interferes with its nuclear targeting. Therefore, we next aimed to investigate whether the pathogenicity is caused by the constitutive activity or by the impairment of nuclear targeting.
To examine whether the constitutive activity results from the observed increase of Thr287 auto-phosphorylation ( Figure 3A and B), we mutated Threonine 287 to Alanine, a mutation that strongly reduces autonomous activity (Fong, Taylor, Means, & Soderling, 1989 
F I G U R E 6
Auto-phosphorylation at the Thr287 site is dispensable for the phenotype caused by the p.Arg292Pro mutation. (A) Representative confocal images of hippocampal neurons transfected on DIV7 with control vector, CAMK2G Arg292Pro (R292P), CAMK2G Thr287Ala (T287A), CAMK2G Thr287Ala/Arg292Pro (T287A/R292P). Transfected neurons are identified by the tdTOMATO (red). (B) Summary bar graphs of total neurite length and arborization measured for each condition and normalized to the control vector (total neurite length: one-way ANOVA, F[3,70] = 69.33, P = 6.39E-21; control vector vs. CAMK2G Arg292Pro , P = 0.0001; CAMK2G Thr287Ala , P = 0.9; CAMK2G Thr287Ala/Arg292Pro , P = 0.0001; CAMK2G Arg292Pro vs. CAMK2G Thr287Ala , P = 0.0001; CAMK2G Thr287Ala/Arg292Pro , P = 0.99; CAMK2G Thr287Ala vs. CAMK2G Thr287Ala/Arg292Pro , P = 0.0001; arborization: one-way ANOVA, F[3,71] = 34.88, P = 5.74E-14; control vector vs. CAMK2G Arg292Pro , P = 0.0001; CAMK2G Thr287Ala , P = 0.9; CAMK2G Thr287Ala/Arg292Pro , P = 0.0001; CAMK2G Arg292Pro vs. CAMK2G Thr287Ala , P = 0.0001; CAMK2G T287A/R292P , P = 0.99; CAMK2G Thr287Ala vs. CAMK2G Thr287Ala/Arg292Pro , P = 0.0001). (C) Representative image of a P20 pup in utero electroporated at E14.5 with CAMK2G Thr287Ala or CAMK2G Thr287Ala/Arg292Pro . tdTOMATO positive cells represent neurons successfully targeted. DAPI (blue) counterstaining is used to identify general cortical structure. resulted in no discernible effects on morphology or neural cell migration ( Figure 6 ). In contrast, expression of CAMK2G Thr287Ala/Arg292Pro was comparably disruptive as CAMK2G Arg292Pro on neuronal morphology and migration ( Figure 6 ). These results indicate that functional consequences of the CAMK2G Arg292Pro mutation are independent of Thr287 phosphorylation.
We next examined whether the p.Arg292Pro mutation gain-offunction requires the catalytic function of the kinase by introducing a p.Lys43Arg mutation, known to severely disable CAMK2G catalytic function. Compared to the severe neurodevelopmental impairments resulting from expression of CAMK2G Arg292Pro , CAMK2G Arg292Pro/Lys43Arg had a significantly milder impact on total neurite length and fully rescued arborization ( Figure 7A ). Moreover, CAMK2G Arg292Pro/Lys43Arg expressing cells targeted at E14.5 by in utero electroporation revealed no discernible migration deficits compared to CAMK2G WT ( Figure 2F , Figure 7C and D), indicating that the pathogenicity of CAMK2G Arg292Pro requires its kinase activity.
Since the introduction of the p.Lys43Arg mutation into the exclusively cytosolic CAMK2G Arg292Pro isoform strongly attenuates the pathogenicity of the Arg292Pro mutation, we hypothesized that the pathogenicity of the p.Arg292Pro mutation is independent of its function as a nuclear Ca/CaM shuttle. To investigate this, we introduced the p.Lys43Arg mutation into the CAMK2G that carries an NLS, resulting in CAMK2G-NLS Arg292Pro . Analysis of the CAMK2G-NLS Lys43Arg/Arg292Pro double mutation showed that the Lys43Arg mutation did not alter the nuclear targeting deficit (Suppl. Fig. S6A and B). Nevertheless, both neuronal maturation and migration were again fully rescued by introducing the p.Lys43Arg mutation (Suppl.
Fig. S6C-E).
Taken together these experiments suggest that the p.Arg292Pro mutation renders CAMK2G constitutively active and impairs neuronal maturation and migration independent of its role as a Ca 2+ /CaM shuttle.
3.1.6
The CAMK2G Arg292Pro analogous mutations in CAMK2A and CAMK2B exhibit similar neurodevelopmental pathogenicity as CAMK2G
Arg292Pro
Given that CAMK2G Arg292Pro exerts the pathogenic phenotype we describe via a non-nuclear function, we hypothesized that the analogous mutations in CAMK2A or CAMK2B lacking an NLS might be similarly disruptive for neurodevelopment, given that they are almost exclusively localized to the cytoplasm. Therefore, we generated the analogous mutations of CAMK2G Arg292Pro in CAMK2A and CAMK2B ( Figure 8A ). We first investigated the basal Thr286 and We next tested whether the expression of CAMK2A Lys291Pro and CAMK2B Lys292Pro impacts the morphological development of cultured primary hippocampal neurons ( Figure 8D ). No changes in neuronal morphology were observed with expression of CAMK2A WT (Figure 8E) . Expression of CAMK2B WT did result in a small but significant decrease in arborization, but without changes in total neurite length ( Figure 8E ). In contrast, expression of either CAMK2A Lys291Pro or CAMK2B Lys292Pro each resulted in substantial alterations of neuronal morphology ( Figure 8D and E).
Lastly, we evaluated the impact of CAMK2A Lys291Pro and CAMK2B Lys292Pro on in vivo neural cell migration. The majority of cells expressing either CAMK2A WT or CAMK2B WT migrated normally to layer 2/3 of the somatosensory cortex ( Figure 8F ). However, expression of either CAMK2A Lys291Pro or CAMK2B Lys292Pro caused a severe disruption of migration, analogous to the effect of CAMK2G Arg292Pro
( Figure 8F ).
Therefore, our findings suggest a strong functional conservation across the major brain-expressed CAMK2 isoforms of the IDassociated CAMK2G p.Arg292Pro mutation for which neurodevelopmental pathogenicity is mediated by a gain-of-function through enhanced cytoplasmic phosphotransferase activity.
DISCUSSION
In the present study, we describe two unrelated patients with severe ID, carrying a de novo CAMK2G p.Arg292Pro mutation and made use of an in vitro morphology and in vivo migration assay to investigate the pathogenicity of this mutation.
Mutations in CAMK2A and CAMK2B have recently been shown to cause ID, severely delayed speech and behavioral issues (Küry et al., 2017) . Apart from these common features, there is much variability between the different CAMK2 patients. The two patients described here carrying a mutation in CAMK2G share similar features with Additionally, mice expressing the CAMK2A Thr305Val/Thr306Ala protein, which lacks auto-inhibitory function, exhibits a two-fold reduction in CAMK2A protein but similarly produces a net gain-of-function phenotype (Elgersma et al., 2002) . Since CAMK2 is highly dependent on a Ca 2+ stimulus for activity, even low expression of a constitutively active form such as CAMK2G Arg292Pro may elicit gain-of-function effects. Future studies using a targeted mouse mutant and genomeedited human pluripotent stem cells would provide further insights regarding the endogenous regulation of CAMK2G Arg292Pro protein levels.
Although the effect of the CAMK2G Arg292Pro mutation has not previously been studied, our finding that its pathogenicity derives from (CAMK2B and CAMK2G) for auto-phosphorylation, which disables the inhibitory function of the auto-regulatory domain and results in Ca 2+ /CaM independent (autonomous) activity. The auto-regulatory domain consists of several residues that participate in auto-inhibition, one of which is located at amino acid position 291 in CAMK2A (Smith, Colbran, Brickey, & Soderling, 1992) . Indeed, for CAMK2A it has previously been shown that mutation of Lysine 291 (equivalent to Arginine 292 in CAMK2G) to Alanine increases the K i for inhibitory peptides and reduced the inhibitory potency of the auto-regulatory domain (Smith et al., 1992) . Notably, mutation of CAMK2A just three residues downstream, from Asparagine 294 to aspartic acid, generates an even greater enhancement of constitutive activity than the phosphomimetic p.Thr286Asp mutation. Therefore, it is possible that the disruptive nature of the Proline substitution in p.Arg292Pro reduces the contribution of the critical Asparagine for auto-inhibition resulting in enhanced constitutive activity (Yang & Schulman, 1999) . Additionally, mutation of CAMK2A Lysine 291 to Glutamic acid reduced the relative K CaM by 50%, thereby increasing CaM binding (Yang & Schulman, 1999) . Hence, these structural and biochemical findings are entirely consistent with our finding that the p.Arg292Pro mutation would generates a constitutively active kinase that facilitates CaM binding and promotes Thr287 phosphorylation that delinks kinase activity from complete dependence on Ca 2+ stimulus for activity.
Our finding that knockdown of CAMK2G affects neuronal arborization, which could be rescued by CAMK2G expression with or without an NLS, but not by heterologous CAMK2A or CAMK2B overexpression indicates that cytosolic CAMK2G plays a unique role in neuronal development, and that loss-of-function mutations or haploinsufficiency could potentially be disruptive. Indeed, according to ExAC, the probability of CAMK2G being LoF intolerant is high (pLI = 0.99). However, to our knowledge no patient with a neurodevelopmental disorder has yet been found carrying an indel or a nonsense mutation in the CAMK2G gene. Interestingly, another CAMK2G candidate variant (CAMK2G c.1075G > A p.Val359Met) was found in a patient with a developmental disorder in the Deciphering Developmental Disorders Study (Deciphering Developmental Disorders Study, 2017) . In contrast to the p.Arg292Pro mutation, this variant is located in the association domain of the protein, which makes it difficult to predict a priori if and how it affects CAMK2G protein function.
Very few studies have looked at the function of CAMK2G in neurons. Only recently, a first hint for CAMK2G having a unique function in spinal cord ganglion cells was published (Ma et al., 2014) . This study indicated that CAMK2G functions as a shuttle to transport Ca 2+ /CaM from the cell surface and cytoplasm to the nucleus, a function that does not require its catalytic activity but depends on phosphorylation of its Thr287 by a second CAMK2 holoenzyme, and on the integrity of its NLS to initiate changes in gene expression in response to specific Ca 2+ signals. Our study further expands the mechanistic evidence underlying the function of CAMK2G in neurons by demonstrating that reduced levels of CAMK2G resulted in a significant elaboration of neuronal morphology. Notably, this effect could be reversed by expression of CAMK2G with or without an NLS, but not by expression of CAMK2A or CAMK2B. Therefore, we conclude that cytosolic CAMK2G functions to constrain dendritic arborization. In contrast, whereas CAMK2A knockdown does not affect dendritic arborization, CAMK2B knockdown has been shown to reduce dendritic arborization of primary hippocampal neurons (Fink et al., 2003) , together suggesting distinct neurodevelopmental functions of the various CAMK2
isoforms.
Even though a subset of CAMK2G isoforms contains an NLS (Takeuchi, Fukunaga, & Miyamoto, 2002) , we did not observe differential effects on neuronal morphology or neural cell migration that were dependent on the presence of the NLS domain. However, we did find that CAMK2G-NLS Arg292Pro is localized predominantly to the cytosol, whereas CAMK2G-NLS WT is located in both the nucleus and cytosol, indicating that the p.Arg292Pro mutation interferes with its nuclear localization. However, given that abrogation of the phosphotransferase activity (via the Lys43Arg mutation) fully rescued the pathogenic effect of the p.Arg292Pro mutation, independently of the presence or absence of the NLS domain, we conclude that the pathogenicity of the p.Arg292Pro mutation is most likely unrelated to its nuclear function.
Our results also demonstrate that the combination of in vitro and in vivo neurodevelopmental assays provide a robust platform for investigating the functional pathogenicity of candidate CAMK2 mutations for ID. Furthermore, by exploiting the wealth of previous data that has been gathered for the CAMK2 protein (Colbran, 1992; Colbran & Brown, 2004; Hanson, Meyer, Stryer, & Schulman, 1994; Hudmon & Schulman, 2002; Rellos et al., 2010; Yang & Schulman, 1999) , we were subsequently able to carefully dissect the biochemical mechanism underlying the pathogenicity of the mutation.
In conclusion, we show that CAMK2G is indispensable for normally developing neurons. Moreover, we have demonstrated that the pathogenicity of the de novo CAMK2G p.Arg292Pro mutation is mediated by a gain-of-function through enhanced constitutive enzymatic activity.
